October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
Publication|Articles|January 25, 2024
- January 2024
- Volume 90
- Issue 1
Pet Peeves: January 2024
Advertisement
New Kid
The new employee who thinks they know more than the
employee who has been here for 24 years.
Articles in this issue
over 2 years ago
Pharmacist Spotlight: Jessica Hung, PharmDalmost 3 years ago
Pharmacists Can Help Children and Adolescents Manage Migrainesalmost 3 years ago
Staying Up-to-Date Is Important for Medication Therapy Managementalmost 3 years ago
Expanding Your Pharmacy Business Through Pharmacy Home Infusion Servicesalmost 3 years ago
Case Studies: January 2024almost 3 years ago
Guilty Pleas Result From Charges of Fraud and Money Launderingalmost 3 years ago
Two Laws Expand Protections for Nursing Employeesalmost 3 years ago
Condition State Management: DiabetesAdvertisement
Related to this article
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
Expert Q&A: Geisinger Investigator Discusses Low Flu Vaccination Rates, ICU Findings in Older Adults
A study author explains how pharmacists can help close vaccination gaps in rural communities and what lower ICU admission rates among vaccinated older adults may mean.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Walgreens adds virtual coverage navigation, Medicare GLP-1 Bridge support, and pharmacist follow-up calls as GLP-1 discontinuation remains high.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cystatin C and the Future of Kidney Function Assessment
2
COVID-19 ‘Is Not Done With Us’: Pharmacist Urges Continued Vaccination Ahead of Seasonal Peaks
3
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
4
Nicotine Vaping Linked to Lower Vascular Function in Young Adults
5